Effects of zinc-desferrioxamine on Plasmodium falciparum in culture.
The zinc-desferrioxamine (Zn-DFO) complex is considered to be more permeative into parasitized erythrocytes than is the metal-free DFO. The former may penetrate the cell and exchange its bound zinc for ferric ions, rendering the iron unavailable for vital parasite functions. The effects of these compounds on the in vitro development of Plasmodium falciparum are compared. The results indicate that Zn-DFO is superior to DFO, especially at concentrations below 20 microM, as shown by decreased levels of hypoxanthine incorporation, lower levels of parasitemia, and interference with the life cycle of the parasite. At low concentrations, DFO even enhanced parasite growth. Such an enhancement was not observed following exposure to Zn-DFO. Experiments in which the compounds were removed from the cultures indicated that parasites treated with Zn-DFO are less likely to recover at a later stage. Since DFO has already been used in humans for the treatment of malaria, its complex with zinc, which is more effective in vitro, should also be examined in vivo.
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology*; D000975:Antioxidants / Q000494:pharmacology*; D003676:Deferoxamine / Q000494:pharmacology*; D004912:Erythrocytes / Q000469:parasitology; D006801:Humans; D007042:Hypoxanthines / Q000378:metabolism; D066298:In Vitro Techniques; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000378:metabolism
D000962:Antimalarials; D000975:Antioxidants; D007042:Hypoxanthines; D003676:Deferoxamine